U.S. FDA Awards National Priority Voucher to sBLA Application for Tecvayli and Darzalex Faspro Combination Based on MajesTEC-3 Trial Results (https://www.myeloma.org/news-events/multiple-myeloma-news/tecvayli-darzalex-faspro-cnpv-pilot-program)